| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Economics of dementia and pharmacoeconomics of dementia therapy |
Fillit, H.;Hill, J.; |
The American Journal of Geriatric Pharmacotherapy |
2005-03-01 |
查看 |
| Effects of rivastigmine treatment on the neuropsychiatric andbehavioral disturbances of nursing home residents with moderate to severeprobable Alzheimer's disease: A 26-week, multicenter, open-label study |
the Rivastigmine Nursing Home Study Team;Cummings, J.L.;Koumaras, B.;Chen, M.;Mirski, D.; |
The American Journal of Geriatric Pharmacotherapy |
2005-09-01 |
查看 |
| Patterns of cholinesterase-inhibitor use in the nursing home setting: Aretrospective analysis |
Dybicz, S.B.;Keohane, D.J.;Gary Erwin, W.;McRae, T.;Shah, S.N.; |
The American Journal of Geriatric Pharmacotherapy |
2006-06-01 |
查看 |
| Cholinesterase Inhibitors: Applying Pharmacokinetics to ClinicalDecision Making |
Gomolin, I.H.;Smith, C.;Jeitner, T.M.; |
The American Journal of Geriatric Pharmacotherapy |
2011-08-01 |
查看 |
| Cholinesterase Inhibitors: Applying Pharmacokinetics to ClinicalDecision Making |
Gomolin, I.H.;Smith, C.;Jeitner, T.M.; |
The American Journal of Geriatric Pharmacotherapy |
2011-08-01 |
查看 |
|
|
